Beat Mullhaupt
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C
Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma
Gordic S, Puippe G, Krauss B, Klotz E, Desbiolles L, Lesurtel M, Mullhaupt B, Pfammatter T, Alkadhi H. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma. Radiology 2016; 280:78-87.
Jan 29, 2016Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma
Jan 29, 2016Radiology 2016; 280:78-87
Gordic Sonja, Puippe Gilbert D, Krauss Bernhard, Klotz Ernst, Desbiolles Lotus, Lesurtel Mickaël, Mullhaupt Beat, Pfammatter Thomas, Alkadhi Hatem
Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Mullhaupt B, Razavi H, Semela D. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Med Wkly 2015; 145:w14221.
Dec 4, 2015Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Dec 4, 2015Swiss Med Wkly 2015; 145:w14221
Bruggmann Philip, Negro Francesco, Bihl Florian, Blach Sarah, Lavanchy Daniel, Mullhaupt Beat, Razavi Homie, Semela David
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
Schmid P, Weber R, Opravil M, Vernazza P, Mullhaupt B, Jochum W, Rauch A, Huber M, Bregenzer A, Swiss HIV Cohort Study. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PloS one 2015; 10:e0138838.
Sep 29, 2015Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
Sep 29, 2015PloS one 2015; 10:e0138838
Schmid Patrick, Weber Rainer, Opravil Milos, Vernazza Pietro, Mullhaupt Beat, Jochum Wolfram, Rauch Andri, Huber Milo, Bregenzer Andrea, Swiss HIV Cohort Study
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Wang H, Pichulik T, Mullhaupt B, Semela D, Dufour J, Bochud P, Bowie A, Kalinke U, Berg T, Weber A, Wiese M, Löffler M, El Maadidi S, Fischer J, Grabski E, Dickhöfer S, Klimosch S, Flannery S, Filomena A, Wolz O, Schneiderhan-Marra N, East-German and Swiss Hepatitis C Virus Study Groups. A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology 2015; 62:1375-87.
Sep 28, 2015A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Sep 28, 2015Hepatology 2015; 62:1375-87
Wang Hui, Pichulik Tica, Mullhaupt Beat, Semela David, Dufour Jean-François, Bochud Pierre-Yves, Bowie Andrew G, Kalinke Ulrich, Berg Thomas, Weber Alexander N R, Wiese Manfred, Löffler Markus W, El Maadidi Souhayla, Fischer Janett, Grabski Elena, Dickhöfer Sabine, Klimosch Sascha, Flannery Sinead M, Filomena Angela, Wolz Olaf-Oliver, Schneiderhan-Marra Nicole, East-German and Swiss Hepatitis C Virus Study Groups
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
Jun 29, 2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Jun 29, 2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F. Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PloS one 2015; 10:e0125214.
Jun 24, 2015Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Jun 24, 2015PloS one 2015; 10:e0125214
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Semela David, Negro Francesco
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
Dec 23, 2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Dec 23, 2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Clinical significance of the CCR5delta32 allele in hepatitis C
Morard I, Negro F, Bochud P, Pascarella S, Semela D, Mullhaupt B, Moradpour D, Malinverni R, Heim M, Gorgievski M, De Gottardi A, Cerny A, Mangia A, Calmy A, Clément S, Swiss Hepatitis C Cohort Study Group. Clinical significance of the CCR5delta32 allele in hepatitis C. PloS one 2014; 9:e106424.
Sep 5, 2014Clinical significance of the CCR5delta32 allele in hepatitis C
Sep 5, 2014PloS one 2014; 9:e106424
Morard Isabelle, Negro Franco, Bochud Pierre-Yves, Pascarella Stéphanie, Semela David, Mullhaupt Beat, Moradpour Darius, Malinverni Raffaele, Heim Markus, Gorgievski Meri, De Gottardi Andrea, Cerny Andrea, Mangia Alessandra, Calmy Alexandra, Clément Sophie, Swiss Hepatitis C Cohort Study Group
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
Lange C, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud P, Hiroshima Liver Study Group, Mullhaupt B, Malinverni R, Heim M, Miki D, Ochi H, Nischalke H, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour J, Gorgievski-Hrisoho M, Swiss Hepatitis C Cohort Study Group. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PloS one 2013; 8:e64053.
May 29, 2013Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
May 29, 2013PloS one 2013; 8:e64053
Lange Christian M, Negro Francesco, Semela David, Kutalik Zoltán, Müller Tobias, Spengler Ulrich, Berg Thomas, Chayama Kazuaki, Moradpour Darius, Bochud Pierre-Yves, Hiroshima Liver Study Group, Mullhaupt Beat, Malinverni Raffaele, Heim Markus H, Miki Daiki, Ochi Hidenori, Nischalke Hans-Dieter, Bojunga Jörg, Bibert Stéphanie, Morikawa Kenichi, Gouttenoire Jérôme, Cerny Andreas, Dufour Jean-François, Gorgievski-Hrisoho Meri, Swiss Hepatitis C Cohort Study Group
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
Lange C, Bochud P, Kutalik Z, Moradpour D, Semela D, Negro F, Mullhaupt B, Malinverni R, Kaiser L, Heim M, Cerny A, Cellerai C, Dufour J, Bibert S, Swiss Hepatitis C Cohort Study Group. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol 2013; 59:504-9.
May 9, 2013Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
May 9, 2013J Hepatol 2013; 59:504-9
Lange Christian M, Bochud Pierre-Yves, Kutalik Zoltán, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Malinverni Raffaele, Kaiser Laurent, Heim Markus H, Cerny Andreas, Cellerai Cristina, Dufour Jean-François, Bibert Stéphanie, Swiss Hepatitis C Cohort Study Group
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
Rau M, Geier A, Mullhaupt B, Semela D, Moradpour D, Dufour J, Dill M, Schmitt J, Weisskopf M, Becker P, Manser C, Russmann S, Stickel F, Swiss Hepatitis C Cohort Study Group (SCCS). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. J Hepatol 2012; 58:669-75.
Nov 27, 2012Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
Nov 27, 2012J Hepatol 2012; 58:669-75
Rau Monika, Geier Andreas, Mullhaupt Beat, Semela David, Moradpour Darius, Dufour Jean-François, Dill Michael T, Schmitt Johannes, Weisskopf Michael, Becker Philip P, Manser Christine N, Russmann Stefan, Stickel Felix, Swiss Hepatitis C Cohort Study Group (SCCS)
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Kuske L, Dufour J, Cerny A, Malinverni R, Heim M, Malé P, Moradpour D, Semela D, Negro F, Mullhaupt B, Mensen A, Swiss Hepatitis C Cohort Study. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss Med Wkly 2012; 142:w13651.
Aug 6, 2012Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Aug 6, 2012Swiss Med Wkly 2012; 142:w13651
Kuske Lorenz, Dufour Jean-François, Cerny Andreas, Malinverni Raffaele, Heim Markus H, Malé Pierre Jean, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Mensen Armand, Swiss Hepatitis C Cohort Study
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection
Patin E, Stewart G, Booth D, George J, Casanova J, Bréchot C, Rice C, Talal A, Jacobson I, Bourlière M, Theodorou I, Poynard T, Negro F, Pol S, Bochud P, Abel L, Swiss Hepatitis C Cohort Study Group, International Hepatitis C Genetics Consortium, Suppiah V, Martinetti G, Hirsch H, Kutalik Z, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Mullhaupt B, Semela D, Dufour J, Heim M, Moradpour D, Cerny A, Malinverni R, French ANRS HC EP 26 Genoscan Study Group. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology 2012; 143:1244-52.e1-12.
Jul 27, 2012Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection
Jul 27, 2012Gastroenterology 2012; 143:1244-52.e1-12
Patin Etienne, Stewart Graeme, Booth David R, George Jacob, Casanova Jean-Laurent, Bréchot Christian, Rice Charles M, Talal Andrew H, Jacobson Ira M, Bourlière Marc, Theodorou Ioannis, Poynard Thierry, Negro Francesco, Pol Stanislas, Bochud Pierre-Yves, Abel Laurent, Swiss Hepatitis C Cohort Study Group, International Hepatitis C Genetics Consortium, Suppiah Vijayaprakash, Martinetti Gladys, Hirsch Hans, Kutalik Zoltán, Guergnon Julien, Bibert Stéphanie, Nalpas Bertrand, Jouanguy Emmanuelle, Munteanu Mona, Bousquet Laurence, Argiro Laurent, Halfon Philippe, Boland Anne, Mullhaupt Beat, Semela David, Dufour Jean-François, Heim Markus H, Moradpour Darius, Cerny Andreas, Malinverni Raffaele, French ANRS HC EP 26 Genoscan Study Group
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
Jul 19, 2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Jul 19, 2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
Jan 11, 2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Jan 11, 2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Bochud P, Negro F, Francioli P, Malinverni R, Cerny A, Moradpour D, Heim M, Borovicka J, Mullhaupt B, Dufour J, Bochud M, Overbeck K, Cai T, Swiss Hepatitis C Cohort Study Group. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology 2009; 51:655-66.
Oct 1, 2009Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Oct 1, 2009Journal of hepatology 2009; 51:655-66
Bochud Pierre-Yves, Negro Francesco, Francioli Patrick, Malinverni Raffaele, Cerny Andreas, Moradpour Darius, Heim Markus, Borovicka Jan, Mullhaupt Beat, Dufour Jean-François, Bochud Murielle, Overbeck Kathrin, Cai Tao, Swiss Hepatitis C Cohort Study Group
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
Riener M, Jochum W, Moch H, Fritzsche F, Wild P, Neuhaus P, Bahra M, Clavien P, Mullhaupt B, Hellerbrand C, Probst-Hensch N, Samaras P, Pestalozzi B, Breitenstein S, Soll C, Liewen H, Stenner F, Kristiansen G. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology (Baltimore, Md.) 2009; 49:1602-9.
May 1, 2009Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
May 1, 2009Hepatology (Baltimore, Md.) 2009; 49:1602-9
Riener Marc-Oliver, Jochum Wolfram, Moch Holger, Fritzsche Florian, Wild Peter, Neuhaus Peter, Bahra Marcus, Clavien Pierre-Alain, Mullhaupt Beat, Hellerbrand Claus, Probst-Hensch Nicole, Samaras Panagiotis, Pestalozzi Bernhard Cornelius, Breitenstein Stefan, Soll Christopher, Liewen Heike, Stenner Frank, Kristiansen Glen
Antigen kinetics determines immune reactivity
Johansen P, Bot A, Speck R, Gerlach T, Mullhaupt B, Senti G, Lang K, Manolova V, Smith K, Der-Sarkissian A, Qiu Z, Rettig L, Storni T, Kündig T. Antigen kinetics determines immune reactivity. Proceedings of the National Academy of Sciences of the United States of America 2008; 105:5189-94.
Apr 1, 2008Antigen kinetics determines immune reactivity
Apr 1, 2008Proceedings of the National Academy of Sciences of the United States of America 2008; 105:5189-94
Johansen Pål, Bot Adrian, Speck Roberto F, Gerlach Tilman, Mullhaupt Beat, Senti Gabriela, Lang Karl S, Manolova Vania, Smith Kent A, Der-Sarkissian Ani, Qiu Zhiyong, Rettig Lorna, Storni Tazio, Kündig Thomas M
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT
Wildi S, Gubler C, Hany T, Petrowsky H, Clavien P, Jochum W, Gerlach T, Fried M, Mullhaupt B. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. Journal of clinical ultrasound : JCU 2008; 36:20-6.
Jan 1, 2008Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT
Jan 1, 2008Journal of clinical ultrasound : JCU 2008; 36:20-6
Wildi Stephan M, Gubler Christoph, Hany Thomas, Petrowsky Henrik, Clavien Pierre A, Jochum Wolfram, Gerlach Tilman, Fried Michael, Mullhaupt Beat